About
Professional SummaryDr. Sandeep Rajput is currently working as Postdoctoral Research Associate at Washington University School of Medicine, USA. He obtained his Ph.D. in Molecular Biochemistry from Southern Illinois University, USA. His main area of interest focuses on Pharmacology and Toxicology, Biomedical Sciences, and Molecular Sciences. His area of expertise includes Cancer Biology, Chemoresistance, Signaling Pathways, Anticancer Drug Therapy, Drug Mechanisms, Targeted therapy, Mechanism of Action, Stem Cells, microRNA, and Protein Biochemistry. He has 8 publications in journals as author/co-author.
Education
Academic Background-
Ph.D. Southern Illinois University, USA Molecular Biochemistry | Completed: 2006
Publications (10)
Selected Scholarly Contributions
2017
Beyond genomics: biologic insights from the CPTAC proteogenomic analysis of breast cancer.
Sandeep Rajput
2016
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer.
Sandeep Rajput
2016
Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.
Sandeep Rajput
2014
TLR4 is a novel determinant of the response to paclitaxel in breast cancer.
Sandeep Rajput
2013
Targeting acetyl-CoA carboxylases: Small molecular inhibitors and their therapeutic potential.
Sandeep Rajput
2012
Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.
Sandeep Rajput
2012
Mouse aldo-keto reductases: AKR1B8 is an ortholog of human AKR1B10.
Sandeep Rajput
2010
Role of inflammation in cancer initiation, cancer progression and cancer metastasis.
Sandeep Rajput
2010
2009